Table 4.
Tissue | FGFR3 gain | FGFR3 loss |
---|---|---|
Normal bladder tissue (N = 37) | 0 | 0 |
Primary tumor (N = 121) | 1 (0.8%) | 1 (0.8%) |
Metastasis (N = 33) | 1 (3.0%) | 4 (12.1%) |
FGFR3 mutant (N = 6) | 1 (16.7%) | 0 |
Tissue | FGFR3 gain | FGFR3 loss |
---|---|---|
Normal bladder tissue (N = 37) | 0 | 0 |
Primary tumor (N = 121) | 1 (0.8%) | 1 (0.8%) |
Metastasis (N = 33) | 1 (3.0%) | 4 (12.1%) |
FGFR3 mutant (N = 6) | 1 (16.7%) | 0 |